Good Audience Feedback for all New Mon-Tues K-drama Life, Risky Romance, and Thirty But Seventeen

This Monday has three new K-drama premieres which caught me off guard since I’ve been on a Wed-Thurs Why Secretary Kim haze the last few weeks. First ups is major props to smaller cable network jTBC for breaking it’s own premiere record as medical drama Life  with Lee Dong Wook and Jo Seung Woo which brought 4.334% which broke the first episode premiere record set three months ago by Pretty Noona Who Buys Me Food (Something in the Rain). Unfortunately the prime time dramas continued with low rating streak as SBS new arrival Thirty But Seventeen started off with 5.7% and 7.1% and bringing up the rear was MBC‘s medical rom-com Risky Romance with 4.1% and 3.5%. The already airing KBS drama Are You Human Too stayed steady with 4.6% and 5.6%. What’s promising all around is K-netizen feedback from South Korea with across the board good reviews for all three newcomers – audiences like the fun of both Thirty and Risky Romance and find Life critically impressive.

Be Sociable, Share!

Comments

Good Audience Feedback for all New Mon-Tues K-drama Life, Risky Romance, and Thirty But Seventeen — 8 Comments

  1. I want to watch “Life” for Jo Seung Woo and PD Hong, but medical theme scares me off. Of the three new premieres, I am most likely to check “30 but 17”.

  2. Been on a Kdrama hiatus for a little while as I binge on chinese and japanese drama. But now that Life and Jo Seungwoo is here, i cant stay away anymore. I just hope someone sub it already.
    Been waiting for this drama for ages…

  3. I’m truly excited for all the new dramas! Life is nowhere to be found in the US so Netflix probably has the rights for it *sigh*

    I’m trying to manage my expectations for it so I don’t get dissapointed like so many times in the past. The drama is stacked from top to bottom but everything still has to come together just right and I’m praying it does.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.